Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID

NCT: NCT07714889 · WITHDRAWN

NCT IDNCT07714889
StatusWITHDRAWN
SponsorToivoa Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate Toivoa-004 as an experimental digital therapeutic for persons with Long COVID suffering from anxiety or depression. This study will evaluate the completion rates of the Toivoa-004 program and survey the user's experience upon completion. Changes in anxiety and depression scores will be monitored during the study.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑